Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DX25F6XPH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $16,250
Award facts
- Contract value 100% obligated
- $16,249.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 for STELARA 90 mg/ml syringes on July 24, 2025. This delivery order, which carries an ultimate completion date of August 14, 2025, was issued without a set-aside designation and is funded through the Defense Logistics Agency's Medical Supply Chain division. The award represents a single delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion contract vehicle valid through November 2026 that enables the agency to procure pharmaceutical products and medical supplies for Department of Defense healthcare facilities worldwide.
Stelara is a biologic medication used to treat various inflammatory conditions, and this procurement reflects the Defense Logistics Agency's ongoing need to maintain adequate pharmaceutical inventory across military health systems. DMS Pharmaceutical Group has established itself as a key supplier within the federal pharmaceutical supply chain, consistently securing contracts for branded and generic prescription drugs, biologics, vaccines, and specialty medications. The firm's status as a woman-owned small business, combined with its comprehensive pharmaceutical distribution capabilities and long-standing registration in the System for Award Management since 2001, positions it as a qualified vendor capable of meeting the Department of Defense's specialized medical supply requirements.
Quick answers
Who was awarded contract SPE2DX25F6XPH?
SPE2DX25F6XPH was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on July 24, 2025.
How much is contract SPE2DX25F6XPH worth?
The government has obligated $16,250 on SPE2DX25F6XPH.
Is contract SPE2DX25F6XPH an order under another contract?
Yes. SPE2DX25F6XPH is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XPH competed?
The extent of competition for SPE2DX25F6XPH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award